Hyperglycemia stimulates increased fetal insulin secretion resulting in hyperinsulinemia, which antagonizes glucocorticoids and promotes the synthesis and release of alveolar type II cell surface active substances, resulting in decreased fetal lung surface active substance production and secretion and delayed fetal lung maturation [24]. The gene discussed is INS; the disease is hyperinsulinism.